Trastuzumab in Treating Women With HER2-Positive Early Breast Cancer

- The folks at National Cancer Institute (NCI) are studying the effects of trastuzumab; parenteral chemotherapy on Breast Cancer in females ages 18 years and older. This clinical trial is slated to start October 2007.

Overall Study Contact Info
StatusName Contact Phone
Recruiting

This study is officially titled, "Persephone: Duration of Trastuzumab With Chemotherapy in Women With Early Stage Breast Cancer: Six Months Versus Twelve."

Locations

Addenbrooke's Hospital

Cambridge, England - Recruiting

Cumberland Infirmary

Carlisle, England - Recruiting

Derbyshire Royal Infirmary

Derby, England - Recruiting

Eastbourne District General Hospital

Eastbourne, England - Recruiting

Luton and Dunstable Hospital

Luton, England - Recruiting

Clatterbridge Centre for Oncology

Merseyside, England - Recruiting

James Cook University Hospital

Middlesbrough, England - Recruiting

Mount Vernon Cancer Centre at Mount Vernon Hospital

Northwood, England - Recruiting

Peterborough Hospitals Trust

Peterborough, England - Recruiting

New Cross Hospital

Wolverhampton, England - Recruiting

Aberdeen Royal Infirmary

Aberdeen, Scotland - Recruiting

For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.